New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

For more than 12 years, Abbott's cancer diagnostics business has helped expand access to colorectal cancer screening through ...

Lynch syndrome is a symptomless genetic condition that increases the risk of developing multiple cancers. 95% of Americans ...

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening ...

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening ...

Quest Diagnostics (NYSE:DGX) and Waters Corporation announced a collaboration to expand access to the Onclarity ...

In recognition of Breast Cancer Awareness Month, medical experts from Baystate Health discussed risk factors, screening recommendations, and treatment advances with 22News.

A new DNA test could help doctors determine which men with prostate cancer need more aggressive treatment and which may be spared additional therapy, offering fresh hope of reducing the treatment ...

Making genetic testing more widely available could save the NHS £4m a year - and spare thousands of breast cancer patients ...

The global breast cancer screening and diagnostics market is projected to roughly double from $5.9 billion in 2026 to $12.15 billion by 2036, a new Research and Markets report finds, as GE HealthCare, ...